ENGINEERING CANCER'S END

Serial Number 98597076
602

Registration Progress

Application Filed
Jun 12, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Abandonment Notice E-Mailed - Failure to Respond
Due: Sep 15, 2025 49 days
Revival assistance for abandoned trademark

Trademark Image

ENGINEERING CANCER'S END

Basic Information

Serial Number
98597076
Filing Date
June 12, 2024
Abandonment Date
July 1, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 15, 2025
Classes
016

Rights Holder

H. Lee Moffitt Cancer Center and Research Institute, Inc.

03
Address
12902 Magnolia Drive
Tampa, FL 33612

Ownership History

H. Lee Moffitt Cancer Center and Research Institute, Inc.

Original Applicant
03
Tampa, FL

Legal Representation

Attorney
Corey K. Cho

USPTO Deadlines

Next Deadline
49 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
September 15, 2025

Application History

10 events
Date Code Type Description Documents
Jul 15, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 15, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 27, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 27, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 31, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 31, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 31, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 31, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 30, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Publications, namely, printed instructional and teaching materials, brochures, pamphlets, bulletins, newsletters and magazines, all in the field of health care, cancer protection, prevention, detection and treatment, medical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases.

Additional Information

Pseudo Mark
ENGINEERING CANCERS END

Classification

International Classes
016